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abstract
 
We have investigated the function of the synaptic vesicle protein Rabphilin-3A in neurotransmitter
release at the squid giant synapse. Presynaptic microinjection of recombinant Rabphilin-3A reversibly inhibited
the exocytotic release of neurotransmitter. Injection of fragments of Rabphilin-3A indicate that at least two dis-
tinct regions of the protein inhibit neurotransmitter release: the NH
 
2
 
-terminal region that binds Rab3A and is
phosphorylated by protein kinases and the two C2 domains that interact with calcium, phospholipid, and 
 
b
 
-addu-
cin. Each of the inhibitory fragments and the full-length protein had separate effects on presynaptic morphology,
suggesting that individual domains were inhibiting a subset of the reactions in which the full-length protein partic-
ipates. In addition to inhibiting exocytosis, constructs containing the NH
 
2
 
 terminus of Rabphilin-3A also per-
turbed the endocytotic pathway, as indicated by changes in the membrane areas of endosomes, coated vesicles,
and the plasma membrane. These results indicate that Rabphilin-3A regulates synaptic vesicle traffic and appears
to do so at distinct stages of both the exocytotic and endocytotic pathways. 
 
key words:
 
endocytosis • exocytosis • GTP-binding proteins • rabs • neurotransmitter release
 
i n t r o d u c t i o n
 
Synaptic vesicles undergo many reactions within pre-
synaptic nerve terminals. Vesicles accumulate at active
zones, the presynaptic sites of neurotransmitter release,
and a subset dock via attachment to the plasma mem-
brane (Couteaux and Pecot-Dechavassine, 1974; Schwei-
zer et al., 1995). In response to calcium influx during a
presynaptic action potential, docked synaptic vesicles
fuse with the plasma membrane to release neurotrans-
mitter into the synaptic cleft (Katz, 1966; Heuser et al.,
1979). After fusion, the vesicle components are endocy-
tosed, probably in a dynamin- and clathrin-dependent
manner, to yield coated vesicles (DeCamilli, 1995). These
coated vesicles lose their coats and coalesce with early
endosomes (Heuser and Reese, 1973; DeHoop et al.,
1994; but see Takei et al., 1996; Koenig and Ikeda,
1996). New vesicles are thought to bud from these en-
dosomes, refill with neurotransmitter and reenter the
pool of vesicles available for docking (Heuser and Reese,
1973; DeCamilli, 1995). The molecular mechanisms
that mediate the transitions through this cycle of exo-
cytosis and endocytosis are largely unknown (Kelly,
1993
 
a
 
; Scheller, 1995; Südhof, 1995; Augustine et al.,
1996).
One potential member of the vesicular trafficking
machinery is the synaptic vesicle–associated protein
Rabphilin-3A. Rabphilin-3A was first identified as a
binding partner of Rab3A (Shirataki et al., 1993, 1994),
a member of the Rab family of GTPases implicated in
vesicle docking/fusion reactions in many systems (Si-
mons and Zerial, 1993; Takai et al., 1996). Rabphilin-
3A binds to the GTP-bound form of Rab3A (Yamaguchi
et al., 1993) and maintains Rab3A in this state by pre-
venting a GTPase-activating protein from catalyzing
GTP hydrolysis by Rab3A (Kishida et al., 1993). The
Rab3A binding site is localized to amino acid residues
40–170 and includes a conserved stretch of cysteines
(Stahl et al., 1996). The NH
 
2
 
-terminal half of Rabphi-
lin-3A also binds to the cytoskeletal protein, 
 
a
 
-actinin,
and enhances its ability to bundle actin filaments (Kato
et al., 1996). The COOH terminus of Rabphilin-3A
contains two C2 domains that bind calcium and phos-
pholipid and are homologous to the C2 domains of
synaptotagmin, a protein suggested to be the calcium
sensor that triggers vesicle fusion (DeBello et al., 1993;
Südhof, 1995). In addition, the C2 domains of Rabphi-
lin-3A bind to the cytoskeletal protein 
 
b
 
-adducin (Miyazaki
et al., 1994), which functions in the assembly of spec-
trin–actin complexes at the plasma membrane (Miche
et al., 1987; Hughes and Bennett, 1995). Although Rab-
philin-3A is associated with synaptic vesicles (Shirataki
et al., 1994; Li et al., 1994), the protein lacks a mem-
brane-spanning region. Instead, Rabphilin-3A is thought
to associate with synaptic vesicles by binding to another
vesicular protein whose identity is not yet clear (Shirataki
et al., 1994; McKiernan et al., 1996; Stahl et al., 1996). 
The biochemical properties of Rabphilin-3A, in par-
ticular its ability to bind calcium, Rab3A, and the cy-
toskeleton, make it a prospective participant in synaptic
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vesicle trafficking (Südhof, 1997). We have examined
the function of this protein in the synaptic vesicle cycle
by microinjecting Rabphilin-3A or protein fragments of
Rabphilin-3A into nerve terminals of the giant synapse
of the squid
 
.
 
 We have found that Rabphilin-3A and two
of its fragments potently inhibit neurotransmitter re-
lease. Further, these reagents differentially affect en-
docytotic compartments. We interpret these results to
indicate that Rabphilin-3A regulates both exo- and en-
docytosis.
 
m a t e r i a l s  a n d  m e t h o d s
 
Electrophysiology
 
Stellate ganglia of the squid, 
 
Loligo pealei
 
, were removed from 10–
20-cm-long animals and perfused with a saline (466 mM NaCl, 54
mM MgCl
 
2
 
, 11 mM CaCl
 
2
 
, 10 mM KCl, 3 mM NaHCO
 
3
 
, 10 mM
HEPES, pH 7.2) oxygenated with a 99.5%-O
 
2
 
/0.5%-CO
 
2
 
 mixture.
During experiments, this solution was cooled to 13–15
 
8
 
C with a
Peltier device (Cambion, Cambridge, MA). All experiments were
performed on an upright Optiphot microscope with a 10
 
3
 
 objec-
tive (Nikon Inc., Melville, NY). A microelectrode containing 3 M
KCl was placed into the presynaptic axon to deliver current
pulses (400–1,000 nA; 0.033 Hz) to elicit action potentials. A sec-
ond electrode containing 3 M KCl was inserted into the postsyn-
aptic cell to record postsynaptic potential (PSPs)
 
1
 
 resulting from
neurotransmitter release in response to a presynaptic action po-
tential. To detect large changes in the rate of spontaneous minia-
ture PSPs, the postsynaptic membrane potential was monitored
at high gain throughout the course of the experiment and re-
corded on a chart recorder. A third electrode, used both for mi-
croinjection of proteins and for recording the presynaptic action
potential, was inserted directly into the presynaptic terminal of
the most distal giant synapse. This injection electrode contained
the proteins or protein fragments in an internal solution de-
signed to mimic squid axoplasm while maintaining proper pro-
tein folding (250 mM NaCl, 50 mM KCl, 50 mM taurine, 125 mM
K-isethionate, 0.5 mM DTT, 35 mM HEPES, pH 7.4).
To estimate the volume of solution injected, 100 
 
m
 
M fluores-
cein dextran (10 kD) was included in the injection electrode. An
Odyssey confocal microscope (Noran Instruments, Middleton,
WI) was used to measure the fluorescence intensity of the termi-
nal throughout the course of the experiment. To determine the
concentration of dextran injected, this fluorescence signal was
compared with a standard calibration curve constructed from
known concentrations of fluorescein dextran in microcuvettes
approximating the path length of the terminal (50 
 
m
 
m; Martin
and Miledi, 1986). This estimate of the intracellular concentra-
tion of fluorescein dextran was then converted to protein con-
centration from the following relationship: [protein]
 
in
 
 
 
5 
 
([F-
dextran]
 
in
 
 3 
 
[protein]
 
pip
 
)/[F-dextran]
 
pip
 
, where [protein]
 
in
 
 
 
5 
 
in-
tracellular concentration of protein; [F-dextran]
 
in
 
 
 
5 
 
intracellular
concentration of fluorescein dextran; [protein]
 
pip
 
 
 
5 
 
concentra-
tion of protein in injection electrode; [F-dextran]
 
pip
 
 
 
5 
 
concen-
tration of fluorescein dextran in injection electrode. 
 
Protein Expression and Purification
 
Recombinant bovine full-length Rabphilin-3A, the HA-tagged
NH
 
2
 
-terminal fragment (residues 1–280), and the HA-tagged
COOH-terminal fragment (residues 396–704) were purified
from the membrane fraction of overexpressing Sf9 insect cells
(Shirataki et al., 1994; Kikuchi et al., 1995). The glutathione-
S-transferase (GST)–COOH-terminal fragment (residues 281–
704) was purified from overexpressing 
 
Escherichia coli
 
 (Shirataki
and Takai, 1995), and the GST carrier was cleaved off from the
COOH-terminal fragment by digestion with thrombin. 
 
Ultrastructural Analysis
 
Electron microscopy.
 
Single presynaptic terminals microinjected
with various reagents were examined with electron microscopy.
Tissue was fixed and processed as described by Sanchez et al.
(1990). Briefly, after microinjection of a Rabphilin-3A protein
that abolished transmitter release or a comparable volume of a
control solution (buffer alone, HA tag, or inactive Rabphilin-3A
fragment), the electrodes were rapidly removed and the entire
ganglion was immersed in fixative containing 2% glutaraldehyde,
800 mM sucrose, and 3% DMSO in 100 mM Na-cacodylate
buffer. After standard histological processing, sections were cut
from each terminal at 50-
 
m
 
m intervals. Each 80-nm-thick section
was magnified 12,000 times using an electron microscope (JEM-
1200ExII; Jeol U.S.A. Inc., Peabody, MA), and every active zone
encountered was photographed and analyzed. This paradigm
yielded 10 or more sections per terminal and resulted in images
of 
 
z
 
200 active zones per terminal. 
For each experimental or control condition, at least two termi-
nals were used and the active zones of the two finally pooled into
one group. Whenever possible, the same batch of fixative solu-
tion was used to preserve both control and experimental termi-
nals to eliminate any sources of variability related to fixation con-
ditions. Photographs of active zones were digitized and analyzed
using commercial software (Image-1; Universal Imaging Corp.,
West Chester, PA). 
 
Vesicle spatial distributions. 
 
Spatial distributions of vesicles were
determined by measuring the distance between the plasma mem-
brane and the center of each synaptic vesicle within 0.5 
 
m
 
m of
the plasma membrane at a given active zone. This was performed
for all active zones in all sections of each terminal. These dis-
tances were binned into 50-nm compartments to yield the aver-
age number of synaptic vesicles located in a particular bin at an
active zone. To further compare these distributions independent
of differences in the total vesicle number, the number of vesicles
in each compartment also have been expressed as a percentage
of the total vesicles at a given active zone. 
 
Surface area measurements. 
 
For each section, the surface area of
the entire plasma membrane of the presynaptic terminal, includ-
ing synaptic and nonsynaptic regions, was determined at low
magnification by measuring the perimeter of the terminal and
multiplying by the section thickness. All other organelles found
within 1.5 
 
m
 
m of the plasma membrane at an active zone were
measured at high magnification as follows: the diameters of
coated vesicles and synaptic vesicles were measured; since these
organelles are spherical and thinner than a section, their areas
were calculated as A
 
 5 
 
4
 
p
 
 
 
r
 
2
 
. The mean diameters of these vesi-
cles were measured and did not change as a consequence of in-
jecting any Rabphilin-3A reagent. The surface area of large or-
ganelles was determined by measuring the perimeter and multi-
plying by section thickness. Some endosome-like structures were
irregularly shaped and others were circular in profile. We believe
these structures represent two distinct classes of endosomes
(Miller and Heuser, 1984; Kelly, 1993
 
b
 
; Mundigl et al., 1993; De-
Hoop et al., 1994) and have therefore categorized their mem-
brane areas separately. 
Five active zones in each section were randomly selected for
surface area measurements. The total area of membranes in each
 
1
 
Abbreviation used in this paper:
 
 PSP, postsynaptic potential.
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membrane compartment for each section was divided by five to
determine the mean amount of membrane per active zone. This
average value was then multiplied by the total number of active
zones present in each section to determine the extrapolated
amount of total membrane per section. This extrapolation was
necessary for meaningful comparisons of the area of the synaptic
membrane compartments to that of the surface area of the
plasma membrane, which includes sites of endocytosis that lie
outside the immediate region of the active zone. Values from 20
sections (from two terminals) were used to calculate the group
values shown in Fig. 4. Grouping the data by terminals instead of
by sections (
 
n
 
 5 
 
2 instead of
 
 
 
20) yielded the same results and fre-
quently displayed even less variance. 
 
r e s u l t s
 
Rabphilin-3A Inhibits Neurotransmitter Release
 
To determine the function of Rabphilin-3A in neu-
rotransmitter release, we began by microinjecting re-
combinant full-length bovine Rabphilin-3A into the
squid giant presynaptic terminal. Microinjection of
Rabphilin-3A into the presynaptic terminal resulted in
a reduction in the postsynaptic potential evoked by pre-
synaptic action potentials (
 
n
 
 5 
 
14; Fig. 1 
 
A
 
). Because
Rabphilin-3A was injected only into the presynaptic
cell, this inhibition of the PSP is due to a reduction in
neurotransmitter release. Rabphilin-3A injection pro-
duced no change in presynaptic resting or action po-
tentials, indicating that inhibition of neurotransmitter
release is not due to an indirect effect on presynaptic
ion channels. Likewise, there was no change in the
waveform of the PSP that would indicate a desynchroni-
zation of neurotransmitter release (Schweizer et al.,
1998). Since the rate of rise of the PSP (
 
d
 
V/
 
dt
 
) is pro-
portional to the amount of transmitter released by the
presynaptic cell (Augustine et al., 1985), this measure
was used to monitor the time course of action of Rab-
philin-3A (Fig. 1 
 
B, top
 
). Inhibition by Rabphilin-3A
proceeded rapidly, beginning 
 
,
 
1 min after starting the
injection. Further, this inhibition was a specific effect
of injecting Rabphilin-3A; neurotransmitter release was
not affected by even larger injections of protein-free
buffer or another C2 domain–containing protein, Doc-2
(not shown).
Rabphilin-3A was capable of inhibiting transmission
completely if the amount of Rabphilin-3A injected into
the terminal was sufficient. To quantify the amount of
Figure 1. Rabphilin-3A inhib-
its neurotransmitter release. Mi-
croinjection of Rabphilin-3A re-
versibly inhibited the postsyn-
aptic potential PSP evoked by
presynaptic action potentials (A).
The time course of Rabphilin-3A
inhibition of PSP slope (d V/dt),
normalized to the maximum value
measured during the experiment
(B), was correlated with the
amount of protein that was mi-
croinjected. Microinjection of
Rabphilin-3A during the time in-
dicated by solid horizontal bars
(top) was monitored by coinjec-
tion of 10 kD fluorescein dex-
tran, which was used to estimate
the concentration of injected
protein (bottom; see methods).
The extent of inhibition was a
function of the intracellular con-
centration of Rabphilin-3A, mea-
sured at the time of peak inhibi-
tion and at 10 min before and af-
ter (C). These data were fit with
the Hill equation; half-maximal
inhibition required z500 nM
Rabphilin-3A. The data points
are the mean 6 SEM of one to
three injections to each concen-
tration.
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Rabphilin-3A required to inhibit neurotransmitter re-
lease, fluorescein-conjugated dextran was used as a vol-
ume marker and injected along with Rabphilin-3A. The
brightness of the dextran within the terminal was mea-
sured to estimate the concentration of Rabphilin-3A in-
jected into the terminal (Fig. 1 
 
B
 
). The amount of neu-
rotransmitter released declined (
 
top
 
) as the amount of
Rabphilin-3A within the terminal increased (
 
bottom
 
).
Because the rate of diffusion of dextran and protein
within the terminal are likely to be different, we esti-
mated the amount of Rabphilin-3A injected only at short
times (
 
,
 
10 min) after the onset of injection, when any
differences in the relative concentrations of the two
should be minimal. The relationship between the peak
concentration of Rabphilin-3A injected and the amount
of inhibition that resulted was determined from several
separate injection experiments (Fig. 1 
 
C
 
). This relation-
ship can be described by the Hill equation, with half-
maximal inhibition requiring 
 
z
 
0.5 
 
m
 
M Rabphilin-3A. 
The inhibition of neurotransmitter release resulting
from Rabphilin-3A injection was reversible. Release be-
gan to recover shortly after terminating the injection,
and proceeded in a manner correlated with the decline
in fluorescence intensity (Fig. 1 
 
B
 
, 
 
bottom
 
). This revers-
ibility is likely to be due to the injected protein diffus-
ing out of the terminal and into the rest of the large
presynaptic neuron, causing a reduction in Rabphilin-
3A concentration within the terminal. The full revers-
ibility of inhibition shows that Rabphilin-3A does not
bind irreversibly to its presynaptic target(s). It also pro-
vides another indication that the inhibition of transmit-
ter release observed with Rabphilin-3A injection is not
a result of mechanical damage to the presynaptic termi-
nal, because such damage is not commonly reversible.
 
Rabphilin-3A Regulates Exo- and Endocytosis
 
To determine the site within the synaptic vesicle cycle
at which Rabphilin-3A acts to inhibit neurotransmitter
release, we used electron microscopy to examine the
morphological consequences of injecting this protein.
Two terminals were injected with sufficient Rabphilin-
3A to abolish PSPs, and then were rapidly fixed. Con-
trol terminals were injected with comparable volumes
of buffer alone, and then processed identically. Active
zones from control terminals or those injected with
Rabphilin-3A both contained an abundance of synaptic
vesicles (Fig. 2). To quantify the spatial distribution of
synaptic vesicles, we have measured the distance be-
tween the plasma membrane and the center of each of
these synaptic vesicles (Hess et al., 1993; Bommert et
al., 1993; Hunt et al., 1994; DeBello et al., 1995) at hun-
dreds of active zones from each set of terminals. Nei-
ther the raw distributions (Fig. 3 
 
A
 
, 
 
left
 
) nor the distri-
butions normalized to the number of total vesicles (Fig.
3 
 
A, right
 
) revealed changes in the spatial distribution
of synaptic vesicles within 0.5 
 
m
 
m of the plasma mem-
brane at the active zones, despite the full inhibition of
neurotransmitter release by Rabphilin-3A. 
To determine whether Rabphilin-3A affects other or-
ganelles of the synaptic vesicle cycle, we next examined
endocytotic as well as exocytotic membrane compart-
ments in terminals injected with Rabphilin-3A. Quanti-
tation of presynaptic membrane cycling usually involves
measuring the surface areas of four membrane-bound
compartments involved in this cycle (Heuser and Reese,
1973): synaptic vesicles (SVs), coated vesicles (CVs), en-
dosomes, and plasma membrane. Since the size and
shape of endosomes change under conditions that af-
fect endocytotic vesicle traffic (Heuser and Reese,
1973; Bucci et al., 1992; DeHoop et al., 1994; Takei et
al., 1996), we have expanded this categorization by sub-
dividing endosomes into two types: irregularly shaped
endosomes (ISE) and circular structures larger than
synaptic vesicles (typically 80–200 nm diameter; vesicu-
lar endosomes, VE). We measured the surface area of
the entire plasma membrane and the surface area of
the other four categories of organelles (SV, CV, ISE,
VE) located within 1.5 
 
m
 
m of the plasma membrane of
the active zone. 
In comparison with controls, terminals injected with
Rabphilin-3A displayed no change in the area of synap-
tic vesicle membrane (Fig. 4), confirming that Rabphi-
lin-3A inhibited exocytosis without affecting the synap-
tic vesicle population. In addition, the protein had no
effect on the area of the irregularly shaped endosomal
compartments. However, terminals injected with Rab-
philin-3A showed a 2.5-fold increase in the membrane
area of vesicular endosomes; this was a significant in-
crease over the area of these organelles in control ter-
minals (
 
P
 
 , 
 
10
 
2
 
5
 
 by 
 
t
 
 test). This increase in both the
size and number of vesicular endosomes was accompa-
nied by a decrease in membrane within coated vesicles
(
 
P
 
 , 
 
0.001) and the plasma membrane (
 
P
 
 , 
 
0.01). The
total amount of membrane was constant between ter-
minals injected with Rabphilin-3A and control solu-
tions (Fig. 4, 
 
bottom
 
 
 
right
 
), supporting the conclusion
that Rabphilin-3A caused a redistribution of membrane
by promoting the formation of vesicular endosomal
structures from coated vesicles and the plasma mem-
brane.
Transmitter release results from the fusion of docked
vesicles (Heuser et al., 1979; Torri-Tarelli et al., 1985),
and terminals inhibited by Rabphilin-3A possessed a
full complement of synaptic vesicles at the active zone.
Thus, while our structural analysis indicates that injec-
tion of Rabphilin-3A can promote the formation of en-
dosomal intermediates, it does not identify the struc-
tural basis for the decrease in neurotransmitter release
caused by injecting this protein. A plausible hypothesis
 247
 
Burns et al.
 
is that this protein also participates in reactions that
make docked synaptic vesicles capable of undergoing
fusion (see 
 
discussion
 
).
 
The Rab3-binding Domain of Rabphilin-3A also Regulates 
Vesicle Traffic
 
Rabphilin-3A consists of several domains with distinct
binding properties. Recombinant fragments of Rabphi-
lin-3A were injected into the presynaptic terminal to
identify the roles of these domains in regulating neu-
rotransmitter release (Fig. 5 
 
A
 
). These fragments should
bind to a subset of Rabphilin-3A targets and thus in-
hibit the function of endogenous Rabphilin-3A by com-
peting for its binding partners inside the cell.
The binding site for Rab3A is within residues 70–140
of the NH
 
2 
 
terminus of Rabphilin-3A (Stahl et al.,
1996). A recombinant fragment of Rabphilin-3A en-
compassing this site (residues 1–280; Fig. 5 
 
A
 
) binds to
Rab3A and inhibits Rab3A-GTPase-activating protein in
a manner similar to the full-length protein (Yamaguchi
et al., 1993; Kishida et al., 1993). This 1–280 fragment
was also a potent inhibitor of transmitter release when
microinjected into the squid presynaptic terminal (Fig.
5 
 
B
 
;
 
 n 
 
5 
 
19). The inhibitory effect was not due to the
Figure 2. Rabphilin-3A injection alters presynaptic structure. Representative images of active zones from terminals injected with either
buffer alone or the HA tag (Control), full-length Rabphilin-3A (Rabphilin-3A), the 1–280 (NH2-terminal) fragment, or the 396–704 (COOH-
terminal) fragment. CV, coated vesicle; ISE, irregularly-shaped endosome; VE, vesicular endosome.
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HA tag of the protein construct because injection of
the HA tag alone had no effect on neurotransmitter re-
lease, even at 500–1,000-fold higher concentrations
(not shown). The inhibition of release produced by the
1–280 fragment was reversible and dose dependent,
with half-maximal inhibition requiring z0.8 mM of this
fragment (Fig. 5 D). Thus, in regard to its specificity, re-
versibility, and dose dependence, the 1–280 fragment
inhibited transmitter release in a manner similar to
that of the full-length protein. This suggests that at
least some of the biological activity of Rabphilin-3A re-
sides within this domain.
To identify the site of action of the 1–280 fragment in
the synaptic vesicle cycle, we examined the morphology
of terminals injected with this fragment. These termi-
nals exhibited marked morphological changes in com-
parison to controls (Fig. 2). Analysis of the spatial distri-
bution of synaptic vesicles revealed two consequences of
injecting the 1–280 fragment. First, this fragment re-
duced the total number of synaptic vesicles within 0.5
mm of the plasma membrane, evident as a decrease in
the number of vesicles in each spatial compartment
(Fig. 3 B, left). However, this fragment did not reduce
vesicle number uniformly; instead, the fragment
changed the shape of the distribution, causing a selec-
tive and significant (P > 0) relative accumulation (or
reduced amount of depletion) of synaptic vesicles lo-
cated 50–100 nm from the plasma membrane (Fig. 3 B,
right). Because the vesicles responsible for transmitter
release must be located in close proximity to the
plasma membrane, it seems likely that the observed
changes in these vesicles are related to the inhibition of
neurotransmitter release produced by this fragment
(see discussion). 
The NH2-terminal fragment could reduce the num-
ber of vesicles by stimulating spontaneous exocytosis,
disrupting vesicle recruitment to the active zone, or by
blocking an endocytotic pathway. To test whether the
1–280 fragment increased spontaneous fusion events,
the frequency of spontaneous miniature PSPs (Miledi,
1967; Mann and Joyner, 1982; Augustine and Eckert,
1984) was estimated by monitoring the resting poten-
tial of the postsynaptic cell at high gain (Miledi, 1973;
Charlton et al., 1982; Augustine et al., 1988). However,
injection of neither this fragment nor any other Rab-
philin-3A derivative produced any change in the postsyn-
aptic resting potential (data not shown), although in-
jection of depolarizing current into the presynaptic ter-
minal to increase the rate of spontaneous release did
elicit small (1–3-mV) postsynaptic depolarizations (Charl-
ton and Atwood, 1977; Augustine and Eckert, 1984).
Thus, the NH2-terminal fragment apparently does not
reduce vesicle number by stimulating the rate of spon-
taneous exocytosis.
To determine whether the NH2-terminal fragment
reduced vesicle number by blocking endocytosis, we
measured organelle surface areas in terminals injected
with the NH2-terminal fragment (Fig. 4). This fragment
reduced the area of synaptic vesicle membrane (P ,
0.01), increased the surface area of the plasma mem-
brane (P , 1025), and reduced the membrane area
(and number) of coated vesicles (P , 0.05). Because
the total amount of organelle membrane did not differ
significantly between groups, (Fig. 4, bottom right), these
results suggest that the membrane lost from the synap-
Figure 3. Differential actions of Rabphilin-3A fragments on the
spatial distribution of synaptic vesicles. The mean number of syn-
aptic vesicles (SVs) found in 50-nm spatial compartments within
the active zone (AZ) was determined for presynaptic terminals in-
jected with control solutions or Rabphilin-3A proteins (left). These
data are also expressed as a percentage of the total number of vesi-
cles at a given active zone (right). Comparison of terminals injected
with buffer alone (n 5 482 active zones) or full-length Rabphilin-
3A (n 5 321 active zones) revealed no change in the spatial distri-
bution of synaptic vesicles despite full inhibition of transmitter re-
lease (A). The spatial distribution of vesicles at active zones from
terminals injected with the 1–280 fragment (B; n 5 423 active
zones) is significantly different from that of controls injected with
buffer alone or an inactive NH2-terminal fragment (n 5 300 active
zones). Likewise, the 396–704 fragment (C; n 5 381 active zones)
also differed from controls injected with the HA tag (n 5 356 ac-
tive zones). Both fragments reduced vesicle number in each spatial
compartment (left) and caused a relative accumulation of vesicles
50–100 nm from the plasma membrane (right).
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tic vesicle pool was relocated to the plasma membrane.
Thus, in contrast to full-length Rabphilin-3A, which ap-
parently promoted endocytosis, the 1–280 fragment ap-
peared to inhibit endocytotic membrane retrieval from
the plasma membrane. 
C2 Domains of Rabphilin-3A also Affect Neurotransmitter 
Release and Membrane Traffic
To determine whether the COOH-terminal domain of
Rabphilin-3A also plays a role in regulating neurotrans-
mitter release, two COOH-terminal fragments were se-
lected for microinjection (Fig. 5 A). One fragment con-
tained the entire COOH-terminal half of Rabphilin
(amino acid residues 281–704), while the second con-
tained only the C2 domains (residues 396–704). Both
of these fragments bind to calcium, lipid, and b-addu-
cin (Yamaguchi et al., 1993; Miyazaki et al., 1994). In-
jection of the 281–704 fragment had no effect on neu-
rotransmitter release (Fig. 6 A, n 5 14), even when
high concentrations of this fragment were injected
(Fig. 6 B). In contrast, injection of the shorter 396–704
fragment inhibited transmitter release reversibly (Fig. 6
C; n 5 16). The effect of this fragment was dose depen-
dent, requiring 1.7 mM protein for half-maximal inhibi-
tion (Fig. 6 D). These results indicate that the COOH-
terminal region also contributes to the biological activ-
ity of Rabphilin-3A.
Like the 1–280 fragment, the 396–704 fragment also
altered the morphology of the presynaptic terminal
(Fig. 2). Compared with control terminals injected with
the HA tag, injection of the COOH-terminal fragment
reduced the number of vesicles in all spatial compart-
ments within 0.5 mm of the plasma membrane (Fig. 3
C, left) and, like the 1–280 fragment, caused a relative
accumulation (P , 1028) of vesicles located 100 nm
from the plasma membrane (Fig. 3 C, right). These sim-
ilarities suggest that the 396–704 fragment might in-
hibit exocytosis via the same mechanisms as the 1–280
fragment. However, unlike the 1–280 fragment, the
396–704 fragment did not appear to inhibit endocytosis
because surface area measurements indicated no statis-
tically significant change in any membrane-bound com-
partment of terminals injected with this fragment (Fig.
4). Thus, while the COOH-terminal domain inhibits
exocytosis, it does not affect the endocytotic pathway.
The COOH-terminal fragment decreased the num-
ber of synaptic vesicles within 0.5 mm of the plasma
membrane (14.3 6 0.5 per active zone compared with
24.7 6 0.8 in controls; n 5 100 active zones; P , 10250;
Fig. 3 C), yet the surface area measurements (which in-
cluded synaptic vesicles up to 1.5 mm from the plasma
membrane) showed no significant difference in synap-
tic vesicle area. Therefore, we wondered if the COOH-
terminal fragment may have prevented the transloca-
tion of vesicles close to the plasma membrane. To as-
sess this possibility, we measured the number of vesicles
located at greater distances from the plasma mem-
brane (0.5–1.0 mm). The COOH-terminal fragment
did not significantly decrease the number of vesicles far
(0.5–1.0 mm) from the plasma membrane (34.1 6 3.9
per active zone, compared with 41.8 6 2.9 in controls;
Figure 4. Rabphilin-3A redis-
tributes membranes among or-
ganelles of the synaptic vesicle cy-
cle. The surface area of several
organelles was measured in 20
sections taken from terminals in-
jected with either full-length Rab-
philin-3A (FL), the 1–280 frag-
ment (N), the 396–704 fragment
(C), or control solutions (Con).
Although these treatments pro-
duced significant changes (*P ,
0.05) in the membrane area of
individual organelles, the total
amount of organellar mem-
brane (bottom right) was con-
served.
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n 5 100 active zones; P . 0.1). The mechanism by
which this fragment reduced vesicle number remains
to be determined; it is possible that it either disperses
the vesicle cluster close to the active zone or prevents
vesicles far from the membrane from translocating to
the release sites.
d i s c u s s i o n
We have found that bovine Rabphilin-3A and its frag-
ments potently inhibit neurotransmitter release when
microinjected into the presynaptic terminal of squid.
Indeed, Rabphilin-3A is the most active reagent among
the .50 that we have injected into the squid giant pre-
synaptic terminal (Burns et al., 1996). Although squid
Rabphilin-3A has not yet been identified, squid presyn-
aptic proteins typically are highly homologous to their
mammalian counterparts (Bommert et al., 1993; Hunt
et al., 1994; DeBello et al., 1995; Burns et al., 1996; O’Con-
nor et al., 1997; Dresbach et al., 1998). Thus, there is
strong reason to suspect that Rabphilin-3A is present
in squid presynaptic terminals and has a primary se-
quence homologous to the mammalian protein that we
have injected. 
Neurotransmitter release requires the functional cou-
pling of exocytosis and endocytosis of synaptic vesicle
membrane (Heuser and Reese, 1973), so that the inhi-
bition of transmitter release that we observed after Rab-
philin-3A injection could have been the result of per-
turbing any stage of the synaptic vesicle trafficking cy-
cle. By combining electrophysiology with quantitative
electron microscopy, we have attempted to correlate
the inhibition of neurotransmitter release with lesions
in particular stages of the synaptic vesicle cycle. Two of
the inhibitory Rabphilin-3A constructs, the full-length
protein and the 1–280 fragment, affected the distribu-
tion of membrane in the endocytotic pathway involved
in recycling of synaptic vesicle components. While the
inhibitory 396–704 fragment had no effect on endocy-
totic compartments, the exocytotic compartments (num-
ber and spatial distribution of synaptic vesicles) of ter-
minals injected with the 396–704 and 1–280 fragments
were almost identical. The differential actions of these
various Rabphilin-3A constructs on exocytosis and en-
docytosis indicate separate and distinct roles for Rab-
philin-3A in the exocytotic and endocytotic pathways.
Therefore, we conclude that Rabphilin-3A is a multi-
functional coordinator of synaptic vesicle traffic. 
Rabphilin-3A Regulates Neurotransmitter Release 
Half-maximal inhibition of transmitter release required
z0.5 mM Rabphilin-3A, which is similar to the dissocia-
tion constant of 0.2 mM reported for Rabphilin-3A
binding to Rab3A in vitro (Yamaguchi et al., 1993).
This suggests that the concentrations that we injected
Figure 5. The NH2-terminal fragment of Rabphilin-3A inhibits
transmitter release. Fragments encompassing the various domains
of Rabphilin-3A were selected for microinjection (A). Microinjec-
tion of the 1–280 fragment inhibited neurotransmitter release in a
manner correlated with the time and extent of injection (B). The
degree of inhibition was a saturating function of the 1–280 frag-
ment, with half-maximal inhibition occurring at 0.8 mM (C). The
data points are the mean 6 SEM of one to seven injections to each
concentration. 
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are relevant to the in vivo biochemistry of the presynap-
tic terminal. The potent inhibitory effects of the NH2-
terminal domain presumably are specific to Rabphilin-
3A, because this domain does not resemble any other
known presynaptic protein. However, because the
COOH-terminal domain of Rabphilin-3A has some se-
quence overlap with other C2 domain proteins, such as
protein kinase C, synaptotagmin, and Doc2 (reviewed
by Südhof and Rizo, 1996), it is possible that the C2 do-
mains of Rabphilin-3A may have acted by perturbing
the function of these other C2 domain proteins. Al-
though we cannot formally exclude this possibility, sev-
eral observations argue against it. First, members of the
C2 protein family each appear to bind to unique sets of
proteins (Südhof and Rizo, 1996). Second, injection of
higher concentrations of Doc2, which also contains two
C2 domains, had no effect on neurotransmitter release.
Third, both the COOH- and the NH2-terminal frag-
ments of Rabphilin-3A had similar effects on the spatial
distribution of synaptic vesicles. Thus, it is likely that
the actions of our reagents are due to specific perturba-
tion of Rabphilin-3A.
Previous work has shown that introduction of Rab-
philin-3A into chromaffin cells stimulates secretion
(Chung et al., 1995) and has no effect on exocytosis in
PC12 cells (Komuro et al., 1996) or mouse eggs (Masu-
moto et al., 1996). It is not yet possible to account for
the diverse actions of full-length Rabphilin-3A in differ-
ent secretory systems. One possibility is that long-term
manipulations of Rabphilin-3A, such as those per-
formed in chromaffin and pheochromocytoma (PC12)
cells, may induce compensatory mechanisms that are
avoided by the acute manipulations we have made (Au-
gustine et al., 1996). For example, genetic knock out of
the Rab3A gene of mice affects the expression and lo-
calization of Rabphilin-3A in neurons (Li et al., 1994),
yet has relatively little effect on transmitter release
(Geppert et al., 1994; Weber et al., 1996). An addi-
tional possibility is that the relative expression levels of
Rabphilin-3A and its binding partners may be an im-
Figure 6. The C2 domains of
Rabphilin-3A regulate transmit-
ter release. Microinjection of the
281–704 fragment of Rabphilin-
3A has no effect on neurotrans-
mitter release (A), even at con-
centrations of several micromo-
lar (B; one to five injections to
each concentration). However,
microinjection of the 396–704
fragment did inhibit release re-
versibly (C). This inhibition was
dose dependent (D; one to seven
injections to each concentra-
tion), with half-maximal inhibi-
tion requiring injection of z1.7
mM of this fragment.
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portant variable in determining the response to exoge-
nous Rabphilin-3A. Finally, because the calcium signal-
ing pathways of these various cell types differ (Augus-
tine and Neher, 1992; Neher and Zucker, 1993;
Heidelberger et al., 1994; Hsu et al., 1996), a calcium-
binding protein such as Rabphilin-3A may play some-
what different roles in different cell types. Although
these factors make it difficult to compare results ob-
tained in these different experimental systems, our ex-
periments are the first investigation into the role of
Rabphilin-3A in neurons and clearly indicate that acute
introduction of Rabphilin-3A potently inhibits synaptic
release of neurotransmitter.
Functional Domains of Rabphilin-3A
Microinjection of full-length Rabphilin-3A and two
Rabphilin-3A protein fragments each produced a po-
tent, dose-dependent inhibition of neurotransmitter
release. The design of our experiment is based on the
assumption that the individual fragments act as com-
petitive inhibitors of endogenous Rabphilin-3A. From
this standpoint, our findings that injection of either
full-length Rabphilin-3A or its individual fragments in-
hibited neurotransmitter release could suggest the sur-
prising conclusion that both reagents caused identical
perturbations, either a gain- or loss-of-function pheno-
type. However, the structural effects of the fragments
and full-length Rabphilin-3A are separate and distinct.
Thus, while both categories of reagents inhibit release,
we conclude that they inhibit via different mechanisms
that are consistent with the basic design assumption.
The actions of the various Rabphilin-3A fragments
define two of the structural domains that are necessary
for Rabphilin-3A function. One domain is within resi-
dues 1–280, which contains the Rab3A binding site and
the sites for phosphorylation by calmodulin-dependent
protein kinase II and cAMP-dependent kinase (Kato et
al., 1994; Numata et al., 1995; Fyske et al., 1995). NH2-
terminal fragments of Rabphilin-3A also inhibit exocy-
tosis in chromaffin cells, PC12 cells, and mouse eggs
(Chung et al., 1995; Komuro et al., 1996; Masumoto et
al., 1996). Future experiments will be needed to deter-
mine whether the Rab3A-binding domain, the phos-
phorylation domain, or some other locus is responsible
for the inhibitory action of this fragment.
The second region that appears to be critical for Rab-
philin-3A function contains the C2 domains (residues
396–704). Our findings are consistent with the effect of
a similar fragment (residues 403–704) on exocytosis in
PC12 cells (Komuro et al., 1996) and mouse eggs (Ma-
sumoto et al., 1996). The C2 domains are known to
bind calcium, phospholipid, and the cytoskeletal pro-
tein b-adducin; the inhibitory action of this fragment
suggests that one or more of these interactions might
be required for the function of Rabphilin-3A in neu-
rotransmitter release. However, it is curious that the
larger 281–704 fragment, which contains the active
396–704 domain, was completely inactive. This longer
fragment also has no effect in PC12 cells or chromaffin
cells (Chung et al., 1995; Komuro et al., 1996). To-
gether, these data suggest that the central region of the
larger fragment (281–395) may act as an autoinhibitory
domain that regulates the binding interactions of the
C2 domains. Alternatively, the longer fragment simply
may lack the conformational requirements for binding
to its targets inside the cell.
Rabphilin-3A Regulates Endocytosis
Several of our results indicate that Rabphilin-3A plays a
role in endocytosis. Injecting full-length Rabphilin-3A
increased the membrane area of vesicular endosomes
and caused a commensurate decrease in the area of
membrane associated with coated vesicles and the
plasma membrane. Manipulations that promote en-
docytotic traffic, such as perturbations of GTP-binding
proteins, frequently cause endosomes to appear as
large, empty vesicles (Bucci et al., 1992; Brady et al.,
1993; DeHoop et al., 1994; Mundigl et al., 1993).
Therefore, the simplest interpretation of our data is
that Rabphilin-3A promoted the retrieval of membrane
from the plasma membrane, which then accumulated
in endosomal compartments. In contrast, the 1–280
fragment caused a decrease in the membrane areas of
synaptic and coated vesicles and an expansion of the
area of the plasma membrane, suggesting that this frag-
ment prevented membrane retrieval from the plasma
membrane by acting as a competitive inhibitor of Rab-
philin-3A. Since Rabphilin-3A is not associated with
clathrin-coated vesicles (Stahl et al., 1996), it appears
that the NH2 terminus of Rabphilin-3A regulates an early
step of membrane retrieval that (a) precedes coated ves-
icle formation, and (b) leads to vesicular endosomes. 
The protein–protein interactions that mediate the
endocytotic actions of Rabphilin-3A are not yet clear.
Although the NH2 terminus of Rabphilin-3A binds
Rab3A, it is generally acknowledged that Rab3A does
not participate in endocytosis (Simons and Zerial,
1993; Takai et al., 1996; Südhof, 1997). Because the
NH2 terminus of Rabphilin-3A also binds to a-actinin
(Miyazaki et al., 1994), which participates in actin fila-
ment bundling, this domain could provide a link be-
tween the synaptic vesicle and the cytoskeleton that is
required for endocytosis. 
How Does Rabphilin-3A Regulate Exocytosis?
The inhibition of transmitter release produced by in-
jection of Rabphilin-3A and its individual domains is
not solely the result of an inhibition of endocytosis. For
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all inhibitory constructs, vesicles were present at the ac-
tive zones despite complete inhibition of transmitter re-
lease. Each inhibitory fragment caused a relative in-
crease in the number of synaptic vesicles 50–100 nm
from the plasma membrane. Particularly dramatic was
the effect of injecting full-length Rabphilin-3A, which
inhibited release without affecting the number or spa-
tial distribution of synaptic vesicles (Fig. 3). By what
mechanism do these reagents prevent vesicles from fus-
ing with the plasma membrane in response to an action
potential? 
Our working hypothesis is that Rabphilin-3A is in-
volved in both docking and priming of synaptic vesi-
cles. We propose that the fragments of Rabphilin-3A,
which should act as competitive inhibitors of Rabphi-
lin-mediated interactions, inhibit the docking reaction.
This would account for the observed relative accumula-
tion of undocked vesicles after injection of these frag-
ments. In contrast, we propose that excess full-length
Rabphilin-3A can function in the docking reaction, but
prevents the priming reaction, perhaps by continuing
to bind to Rab3A and preventing GTP hydrolysis
(Kishida et al., 1993). This block of vesicle priming
could account for our observation that injecting full-
length protein inhibits exocytosis at a stage of the vesi-
cle cycle that is morphologically indistinct, as priming
may be (Parsons et al., 1995). 
If priming involves an increased binding affinity of
the vesicle for the plasma membrane, perturbations of
vesicle priming might not affect the observed number
of docked vesicles, whereas those that act after priming
cause an accumulation of fusion-competent vesicles at
the plasma membrane. Indeed, this model can ration-
alize otherwise puzzling observations that some pertur-
bations of SNARE complex proteins (Söllner et al.,
1993; Schiavo et al., 1995), such as synaptotagmin, syn-
aptobrevin, SNAP, and syntaxin, inhibit exocytosis and
result in an accumulation of docked vesicles (Bommert
et al., 1993; Hunt et al., 1994; DeBello et al., 1995;
Broadie et al., 1995), while other SNARE perturbations
(syntaxin, unc-18, SNAP-25) that inhibit neurotrans-
mitter release have no effect on the number of docked
synaptic vesicles (O’Connor et al., 1997; Dresbach et
al., 1998; Burns, 1996). Thus, we propose that the num-
ber of docked synaptic vesicles can be used to differen-
tiate between a perturbation that acts upstream and
one that acts downstream of vesicle priming. More
work is needed to test the validity of this hypothesis. 
C2 Domain Proteins as Multifunctional Coordinators of 
Membrane Traffic
In summary, our data indicate that Rabphilin-3A is in-
volved in both endocytosis and exocytosis of the synap-
tic vesicle cycle underlying neurotransmitter release,
consistent with the multiple biochemical properties of
Rabphilin-3A. What is the advantage of having such a
multifunctional protein? One of the most striking fea-
tures of the synaptic vesicle cycle is that exocytosis and
endocytosis are coupled to maintain a complement of
synaptic vesicles at each active zone. Involving a cal-
cium-binding protein such as Rabphilin-3A in both en-
docytosis and exocytosis may simultaneously regulate
both and thereby coordinate vesicle pool size. It should
be noted that other C2 domain proteins, particularly
synaptotagmin (Jorgensen et al., 1995; Ullrich et al.,
1994; Zhang et al., 1994; Fukuda et al., 1995) and pro-
tein kinase C (Felder et al., 1992; Robinson et al., 1993;
Gillis et al., 1996), also have been implicated in both
exocytosis and endocytosis. Thus, C2 domain proteins
may serve as an entire family of multifunctional regula-
tors of synaptic vesicle traffic.
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